Release Date: 19/03/18 13:12 Summary: Mr Joseph Bek appointed as Acting Chief Executive Officer Price Sensitive: Yes Download Document 155.47KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status